Azithromycin, Cefixime, Vitamin C, Vitamin D, and Zinc to Treat Mild Covid-19: A Case Report
Keywords:COVID-19, azithromycin, cefixime, vitamin C, vitamin D, zinc.
Background: COVID-19 is a novel acute respiratory disease that first emerged in 2019 and exploded into a
worldwide pandemic. Symptoms range from dry cough, fatigue, fever, and pneumonia in mild cases to acute
respiratory distress in critical cases.
Case Report: The aim of the present case study is to illustrate the benefits of using select antibiotics and
dietary supplements to treat a mild case of COVID-19.
Conclusion: A combination of azithromycin, cefixime, vitamin C, vitamin D, and zinc may potentially be
beneficial for the treatment of moderate COVID-19 symptoms.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions